CCR3 Antibody (5E8) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09149
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 5E8
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Tissue / cell preparation (Human) - human CCR3 transfected into mouse B cell lymphoma L1.2 cells.
Specificity
The mouse monoclonal antibody 5E8 recognizes an extracellular epitope of CD193 (chemokine receptor 3), an approximately 41 kDa protein expressed above all in eosinophils and basophils.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Description
Novus Biologicals Mouse CCR3 Antibody (5E8) - BSA Free (NBP3-09149) is a monoclonal antibody validated for use in Flow. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for CCR3 Antibody (5E8) - BSA Free
Flow Cytometry: CCR3 Antibody (5E8) - BSA Free [NBP3-09149]
Flow Cytometry: CCR3 Antibody (5E8) [NBP3-09149] - Analysis (surface staining) of CD193 in human peripheral blood with anti-human CD193 (5E8) purified, GAM-APC.Applications for CCR3 Antibody (5E8) - BSA Free
Application
Recommended Usage
Flow Cytometry
1-4 ug/ml
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
Phosphate buffered saline (PBS), pH 7.4
Format
BSA Free
Preservative
15mM Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CCR3
Alternate Names
CCR3, CD193
Gene Symbol
CCR3
Additional CCR3 Products
Product Documents for CCR3 Antibody (5E8) - BSA Free
Product Specific Notices for CCR3 Antibody (5E8) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...